Bayer (BAYRY) was ordered by a jury in Georgia, US to pay approximately $2.1B to a plaintiff claiming its Roundup weedkiller caused cancer, Tim Loh of Bloomberg reports. The verdict includes $65M in compensatory and $2B in punitive damage, according to an emailed statement from Arnold & Itkin LLP and Kline & Specter PC, the plaintiff’s firms. Bayer disagrees with the decision and intends to appeal, a spokesman said in an emailed statement, according to Bloomberg.
Meet Your ETF AI Analyst
- Discover how TipRanks' ETF AI Analyst can help you make smarter investment decisions
- Explore ETFs TipRanks' users love and see what insights the ETF AI Analyst reveals about the ones you follow.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on BAYRY:
- Northern Trust selected by Bayer as provider for carbon credit management
- Bayer treatment of NSCLC granted orphan designation
- Bayer price target raised to EUR 26 from EUR 22 at Berenberg
- Bayer could stop selling Roundup weedkiller over legal risks, Reuters says
- Bayer expects improved performance from 2026 onwards